Seoul Pharma Co (XKRX:018680) Accounts Payable & Accrued Expense : ₩3,324 Mil (As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is Seoul Pharma Co Accounts Payable & Accrued Expense?

Seoul Pharma Co's quarterly accounts payable & accrued expense increased from Sep. 2024 (₩2,429 Mil) to Dec. 2024 (₩2,947 Mil) and increased from Dec. 2024 (₩2,947 Mil) to Mar. 2025 (₩3,324 Mil).

Seoul Pharma Co's annual accounts payable & accrued expense increased from Dec. 2022 (₩3,299 Mil) to Dec. 2023 (₩3,416 Mil) but then declined from Dec. 2023 (₩3,416 Mil) to Dec. 2024 (₩2,947 Mil).

Seoul Pharma Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Seoul Pharma Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seoul Pharma Co Accounts Payable & Accrued Expense Chart

Seoul Pharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,104.11

1,999.73

3,299.05

3,415.59

2,946.79

Seoul Pharma Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3,700.33	3,513.40	2,428.59	2,946.79	3,323.61

Seoul Pharma Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Seoul Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Seoul Pharma Co Ltd (XKRX:018680) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

21, Banpo-daero, Seocho-gu, Seoul, KOR, 06710

Website

http://www.seoulpharma.com

Seoul Pharma Co Ltd is engaged in manufacturing and distribution of pharmaceuticals products in South Korea. Its products portfolio consists of drugs for the cardiovascular system, respiratory system, and digestive system, drugs for hypertension, antipyretics, drugs for skin disease, drugs for a cough as well as ointments, among others.

Seoul Pharma Co Headlines

No Headlines